nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—SIGMAR1—Raloxifene—osteoporosis	0.285	0.414	CbGbCtD
Methysergide—HTR6—Raloxifene—osteoporosis	0.214	0.31	CbGbCtD
Methysergide—HTR2B—Raloxifene—osteoporosis	0.191	0.277	CbGbCtD
Methysergide—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00291	1	CbGdCrCtD
Methysergide—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000626	0.00251	CcSEcCtD
Methysergide—Flushing—Zoledronate—osteoporosis	0.000625	0.00251	CcSEcCtD
Methysergide—Malaise—Ethinyl Estradiol—osteoporosis	0.000624	0.0025	CcSEcCtD
Methysergide—Back pain—Pamidronate—osteoporosis	0.000621	0.00249	CcSEcCtD
Methysergide—Somnolence—Estropipate—osteoporosis	0.00062	0.00249	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000615	0.00247	CcSEcCtD
Methysergide—Dyspepsia—Estropipate—osteoporosis	0.000614	0.00246	CcSEcCtD
Methysergide—Insomnia—Raloxifene—osteoporosis	0.000611	0.00245	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000609	0.00244	CcSEcCtD
Methysergide—Insomnia—Ibandronate—osteoporosis	0.000605	0.00243	CcSEcCtD
Methysergide—Dyspepsia—Alendronate—osteoporosis	0.000604	0.00242	CcSEcCtD
Methysergide—Gastrointestinal disorder—Estropipate—osteoporosis	0.000602	0.00241	CcSEcCtD
Methysergide—Fatigue—Estropipate—osteoporosis	0.000601	0.00241	CcSEcCtD
Methysergide—Paraesthesia—Ibandronate—osteoporosis	0.0006	0.00241	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000596	0.00239	CcSEcCtD
Methysergide—Pain—Estropipate—osteoporosis	0.000596	0.00239	CcSEcCtD
Methysergide—Constipation—Estropipate—osteoporosis	0.000596	0.00239	CcSEcCtD
Methysergide—Ill-defined disorder—Pamidronate—osteoporosis	0.000595	0.00239	CcSEcCtD
Methysergide—Alopecia—Zoledronate—osteoporosis	0.000595	0.00239	CcSEcCtD
Methysergide—Dyspepsia—Raloxifene—osteoporosis	0.000594	0.00238	CcSEcCtD
Methysergide—Insomnia—Calcitriol—osteoporosis	0.000592	0.00237	CcSEcCtD
Methysergide—Weight increased—Estradiol—osteoporosis	0.00059	0.00237	CcSEcCtD
Methysergide—Dyspepsia—Ibandronate—osteoporosis	0.000588	0.00236	CcSEcCtD
Methysergide—Pain—Alendronate—osteoporosis	0.000587	0.00236	CcSEcCtD
Methysergide—Constipation—Alendronate—osteoporosis	0.000587	0.00236	CcSEcCtD
Methysergide—Weight decreased—Estradiol—osteoporosis	0.000587	0.00235	CcSEcCtD
Methysergide—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000583	0.00234	CcSEcCtD
Methysergide—Discomfort—Ethinyl Estradiol—osteoporosis	0.000582	0.00234	CcSEcCtD
Methysergide—Somnolence—Calcitriol—osteoporosis	0.000582	0.00233	CcSEcCtD
Methysergide—Malaise—Pamidronate—osteoporosis	0.000579	0.00232	CcSEcCtD
Methysergide—Pain—Raloxifene—osteoporosis	0.000577	0.00232	CcSEcCtD
Methysergide—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000577	0.00232	CcSEcCtD
Methysergide—Fatigue—Ibandronate—osteoporosis	0.000576	0.00231	CcSEcCtD
Methysergide—Chest pain—Risedronate—osteoporosis	0.000575	0.00231	CcSEcCtD
Methysergide—Myalgia—Risedronate—osteoporosis	0.000575	0.00231	CcSEcCtD
Methysergide—Arthralgia—Risedronate—osteoporosis	0.000575	0.00231	CcSEcCtD
Methysergide—Alopecia—Conjugated Estrogens—osteoporosis	0.000573	0.0023	CcSEcCtD
Methysergide—Constipation—Ibandronate—osteoporosis	0.000572	0.00229	CcSEcCtD
Methysergide—Pain—Ibandronate—osteoporosis	0.000572	0.00229	CcSEcCtD
Methysergide—Gastrointestinal pain—Estropipate—osteoporosis	0.00057	0.00229	CcSEcCtD
Methysergide—Back pain—Zoledronate—osteoporosis	0.000567	0.00227	CcSEcCtD
Methysergide—Feeling abnormal—Alendronate—osteoporosis	0.000566	0.00227	CcSEcCtD
Methysergide—Oedema—Ethinyl Estradiol—osteoporosis	0.000565	0.00227	CcSEcCtD
Methysergide—Gastrointestinal pain—Alendronate—osteoporosis	0.000561	0.00225	CcSEcCtD
Methysergide—Pain—Calcitriol—osteoporosis	0.00056	0.00225	CcSEcCtD
Methysergide—Constipation—Calcitriol—osteoporosis	0.00056	0.00225	CcSEcCtD
Methysergide—Convulsion—Pamidronate—osteoporosis	0.000556	0.00223	CcSEcCtD
Methysergide—Gastrointestinal pain—Raloxifene—osteoporosis	0.000552	0.00222	CcSEcCtD
Methysergide—Diarrhoea—Etidronic acid—osteoporosis	0.000551	0.00221	CcSEcCtD
Methysergide—Body temperature increased—Estropipate—osteoporosis	0.000551	0.00221	CcSEcCtD
Methysergide—Abdominal pain—Estropipate—osteoporosis	0.000551	0.00221	CcSEcCtD
Methysergide—Feeling abnormal—Ibandronate—osteoporosis	0.000551	0.00221	CcSEcCtD
Methysergide—Gastrointestinal pain—Ibandronate—osteoporosis	0.000547	0.00219	CcSEcCtD
Methysergide—Myalgia—Pamidronate—osteoporosis	0.000546	0.00219	CcSEcCtD
Methysergide—Arthralgia—Pamidronate—osteoporosis	0.000546	0.00219	CcSEcCtD
Methysergide—Back pain—Conjugated Estrogens—osteoporosis	0.000546	0.00219	CcSEcCtD
Methysergide—Ill-defined disorder—Zoledronate—osteoporosis	0.000544	0.00218	CcSEcCtD
Methysergide—Body temperature increased—Alendronate—osteoporosis	0.000543	0.00218	CcSEcCtD
Methysergide—Abdominal pain—Alendronate—osteoporosis	0.000543	0.00218	CcSEcCtD
Methysergide—Discomfort—Pamidronate—osteoporosis	0.00054	0.00217	CcSEcCtD
Methysergide—Gastrointestinal pain—Calcitriol—osteoporosis	0.000535	0.00215	CcSEcCtD
Methysergide—Abdominal pain—Raloxifene—osteoporosis	0.000534	0.00214	CcSEcCtD
Methysergide—Body temperature increased—Raloxifene—osteoporosis	0.000534	0.00214	CcSEcCtD
Methysergide—Malaise—Zoledronate—osteoporosis	0.000529	0.00212	CcSEcCtD
Methysergide—Abdominal pain—Ibandronate—osteoporosis	0.000528	0.00212	CcSEcCtD
Methysergide—Body temperature increased—Ibandronate—osteoporosis	0.000528	0.00212	CcSEcCtD
Methysergide—Oedema—Pamidronate—osteoporosis	0.000524	0.0021	CcSEcCtD
Methysergide—Abdominal pain—Calcitriol—osteoporosis	0.000517	0.00208	CcSEcCtD
Methysergide—Body temperature increased—Calcitriol—osteoporosis	0.000517	0.00208	CcSEcCtD
Methysergide—Thrombocytopenia—Pamidronate—osteoporosis	0.000513	0.00206	CcSEcCtD
Methysergide—Vomiting—Etidronic acid—osteoporosis	0.000512	0.00206	CcSEcCtD
Methysergide—Oedema peripheral—Estradiol—osteoporosis	0.000511	0.00205	CcSEcCtD
Methysergide—Tachycardia—Pamidronate—osteoporosis	0.000511	0.00205	CcSEcCtD
Methysergide—Rash—Etidronic acid—osteoporosis	0.000508	0.00204	CcSEcCtD
Methysergide—Convulsion—Zoledronate—osteoporosis	0.000508	0.00204	CcSEcCtD
Methysergide—Dermatitis—Etidronic acid—osteoporosis	0.000508	0.00204	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000502	0.00201	CcSEcCtD
Methysergide—Asthenia—Estropipate—osteoporosis	0.0005	0.00201	CcSEcCtD
Methysergide—Chest pain—Zoledronate—osteoporosis	0.000499	0.002	CcSEcCtD
Methysergide—Arthralgia—Zoledronate—osteoporosis	0.000499	0.002	CcSEcCtD
Methysergide—Myalgia—Zoledronate—osteoporosis	0.000499	0.002	CcSEcCtD
Methysergide—Insomnia—Risedronate—osteoporosis	0.000498	0.002	CcSEcCtD
Methysergide—Paraesthesia—Risedronate—osteoporosis	0.000495	0.00198	CcSEcCtD
Methysergide—Discomfort—Zoledronate—osteoporosis	0.000493	0.00198	CcSEcCtD
Methysergide—Asthenia—Alendronate—osteoporosis	0.000493	0.00198	CcSEcCtD
Methysergide—Dyspnoea—Risedronate—osteoporosis	0.000491	0.00197	CcSEcCtD
Methysergide—Convulsion—Conjugated Estrogens—osteoporosis	0.000489	0.00196	CcSEcCtD
Methysergide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000488	0.00196	CcSEcCtD
Methysergide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000487	0.00195	CcSEcCtD
Methysergide—Dyspepsia—Risedronate—osteoporosis	0.000485	0.00195	CcSEcCtD
Methysergide—Constipation—Ethinyl Estradiol—osteoporosis	0.000483	0.00194	CcSEcCtD
Methysergide—Flushing—Estradiol—osteoporosis	0.000482	0.00193	CcSEcCtD
Methysergide—Chest pain—Conjugated Estrogens—osteoporosis	0.000481	0.00193	CcSEcCtD
Methysergide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000481	0.00193	CcSEcCtD
Methysergide—Myalgia—Conjugated Estrogens—osteoporosis	0.000481	0.00193	CcSEcCtD
Methysergide—Asthenia—Ibandronate—osteoporosis	0.00048	0.00192	CcSEcCtD
Methysergide—Nausea—Etidronic acid—osteoporosis	0.000479	0.00192	CcSEcCtD
Methysergide—Oedema—Zoledronate—osteoporosis	0.000478	0.00192	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000477	0.00191	CcSEcCtD
Methysergide—Diarrhoea—Estropipate—osteoporosis	0.000477	0.00191	CcSEcCtD
Methysergide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000476	0.00191	CcSEcCtD
Methysergide—Fatigue—Risedronate—osteoporosis	0.000475	0.00191	CcSEcCtD
Methysergide—Insomnia—Pamidronate—osteoporosis	0.000474	0.0019	CcSEcCtD
Methysergide—Constipation—Risedronate—osteoporosis	0.000471	0.00189	CcSEcCtD
Methysergide—Pain—Risedronate—osteoporosis	0.000471	0.00189	CcSEcCtD
Methysergide—Paraesthesia—Pamidronate—osteoporosis	0.00047	0.00189	CcSEcCtD
Methysergide—Diarrhoea—Alendronate—osteoporosis	0.00047	0.00188	CcSEcCtD
Methysergide—Asthenia—Calcitriol—osteoporosis	0.00047	0.00188	CcSEcCtD
Methysergide—Thrombocytopenia—Zoledronate—osteoporosis	0.000468	0.00188	CcSEcCtD
Methysergide—Dyspnoea—Pamidronate—osteoporosis	0.000467	0.00187	CcSEcCtD
Methysergide—Tachycardia—Zoledronate—osteoporosis	0.000467	0.00187	CcSEcCtD
Methysergide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000466	0.00187	CcSEcCtD
Methysergide—Somnolence—Pamidronate—osteoporosis	0.000466	0.00187	CcSEcCtD
Methysergide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000462	0.00185	CcSEcCtD
Methysergide—Diarrhoea—Raloxifene—osteoporosis	0.000462	0.00185	CcSEcCtD
Methysergide—Dyspepsia—Pamidronate—osteoporosis	0.000461	0.00185	CcSEcCtD
Methysergide—Dizziness—Estropipate—osteoporosis	0.000461	0.00185	CcSEcCtD
Methysergide—Oedema—Conjugated Estrogens—osteoporosis	0.000461	0.00185	CcSEcCtD
Methysergide—Alopecia—Estradiol—osteoporosis	0.000459	0.00184	CcSEcCtD
Methysergide—Diarrhoea—Ibandronate—osteoporosis	0.000457	0.00184	CcSEcCtD
Methysergide—Dizziness—Alendronate—osteoporosis	0.000454	0.00182	CcSEcCtD
Methysergide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000452	0.00181	CcSEcCtD
Methysergide—Fatigue—Pamidronate—osteoporosis	0.000452	0.00181	CcSEcCtD
Methysergide—Gastrointestinal pain—Risedronate—osteoporosis	0.000451	0.00181	CcSEcCtD
Methysergide—Tachycardia—Conjugated Estrogens—osteoporosis	0.00045	0.0018	CcSEcCtD
Methysergide—Pain—Pamidronate—osteoporosis	0.000448	0.0018	CcSEcCtD
Methysergide—Constipation—Pamidronate—osteoporosis	0.000448	0.0018	CcSEcCtD
Methysergide—Diarrhoea—Calcitriol—osteoporosis	0.000448	0.0018	CcSEcCtD
Methysergide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000447	0.00179	CcSEcCtD
Methysergide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000447	0.00179	CcSEcCtD
Methysergide—Dizziness—Raloxifene—osteoporosis	0.000447	0.00179	CcSEcCtD
Methysergide—Vomiting—Estropipate—osteoporosis	0.000443	0.00178	CcSEcCtD
Methysergide—Dizziness—Ibandronate—osteoporosis	0.000442	0.00177	CcSEcCtD
Methysergide—Rash—Estropipate—osteoporosis	0.00044	0.00176	CcSEcCtD
Methysergide—Dermatitis—Estropipate—osteoporosis	0.000439	0.00176	CcSEcCtD
Methysergide—Back pain—Estradiol—osteoporosis	0.000437	0.00175	CcSEcCtD
Methysergide—Vomiting—Alendronate—osteoporosis	0.000437	0.00175	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000436	0.00175	CcSEcCtD
Methysergide—Abdominal pain—Risedronate—osteoporosis	0.000436	0.00175	CcSEcCtD
Methysergide—Body temperature increased—Risedronate—osteoporosis	0.000436	0.00175	CcSEcCtD
Methysergide—Rash—Alendronate—osteoporosis	0.000433	0.00174	CcSEcCtD
Methysergide—Insomnia—Zoledronate—osteoporosis	0.000433	0.00174	CcSEcCtD
Methysergide—Dermatitis—Alendronate—osteoporosis	0.000433	0.00174	CcSEcCtD
Methysergide—Feeling abnormal—Pamidronate—osteoporosis	0.000432	0.00173	CcSEcCtD
Methysergide—Paraesthesia—Zoledronate—osteoporosis	0.00043	0.00172	CcSEcCtD
Methysergide—Vomiting—Raloxifene—osteoporosis	0.000429	0.00172	CcSEcCtD
Methysergide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000428	0.00172	CcSEcCtD
Methysergide—Dyspnoea—Zoledronate—osteoporosis	0.000427	0.00171	CcSEcCtD
Methysergide—Rash—Raloxifene—osteoporosis	0.000426	0.00171	CcSEcCtD
Methysergide—Dermatitis—Raloxifene—osteoporosis	0.000425	0.00171	CcSEcCtD
Methysergide—Somnolence—Zoledronate—osteoporosis	0.000425	0.00171	CcSEcCtD
Methysergide—Vomiting—Ibandronate—osteoporosis	0.000425	0.00171	CcSEcCtD
Methysergide—Rash—Ibandronate—osteoporosis	0.000422	0.00169	CcSEcCtD
Methysergide—Dermatitis—Ibandronate—osteoporosis	0.000421	0.00169	CcSEcCtD
Methysergide—Dyspepsia—Zoledronate—osteoporosis	0.000421	0.00169	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00042	0.00168	CcSEcCtD
Methysergide—Ill-defined disorder—Estradiol—osteoporosis	0.000419	0.00168	CcSEcCtD
Methysergide—Insomnia—Conjugated Estrogens—osteoporosis	0.000417	0.00167	CcSEcCtD
Methysergide—Vomiting—Calcitriol—osteoporosis	0.000416	0.00167	CcSEcCtD
Methysergide—Nausea—Estropipate—osteoporosis	0.000414	0.00166	CcSEcCtD
Methysergide—Abdominal pain—Pamidronate—osteoporosis	0.000414	0.00166	CcSEcCtD
Methysergide—Body temperature increased—Pamidronate—osteoporosis	0.000414	0.00166	CcSEcCtD
Methysergide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000414	0.00166	CcSEcCtD
Methysergide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000413	0.00166	CcSEcCtD
Methysergide—Rash—Calcitriol—osteoporosis	0.000413	0.00166	CcSEcCtD
Methysergide—Fatigue—Zoledronate—osteoporosis	0.000412	0.00165	CcSEcCtD
Methysergide—Dermatitis—Calcitriol—osteoporosis	0.000412	0.00165	CcSEcCtD
Methysergide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000411	0.00165	CcSEcCtD
Methysergide—Somnolence—Conjugated Estrogens—osteoporosis	0.00041	0.00164	CcSEcCtD
Methysergide—Constipation—Zoledronate—osteoporosis	0.000409	0.00164	CcSEcCtD
Methysergide—Pain—Zoledronate—osteoporosis	0.000409	0.00164	CcSEcCtD
Methysergide—Nausea—Alendronate—osteoporosis	0.000408	0.00164	CcSEcCtD
Methysergide—Malaise—Estradiol—osteoporosis	0.000407	0.00163	CcSEcCtD
Methysergide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000405	0.00163	CcSEcCtD
Methysergide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000405	0.00163	CcSEcCtD
Methysergide—Nausea—Raloxifene—osteoporosis	0.000401	0.00161	CcSEcCtD
Methysergide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000398	0.0016	CcSEcCtD
Methysergide—Fatigue—Conjugated Estrogens—osteoporosis	0.000397	0.00159	CcSEcCtD
Methysergide—Nausea—Ibandronate—osteoporosis	0.000397	0.00159	CcSEcCtD
Methysergide—Asthenia—Risedronate—osteoporosis	0.000395	0.00159	CcSEcCtD
Methysergide—Feeling abnormal—Zoledronate—osteoporosis	0.000394	0.00158	CcSEcCtD
Methysergide—Constipation—Conjugated Estrogens—osteoporosis	0.000394	0.00158	CcSEcCtD
Methysergide—Pain—Conjugated Estrogens—osteoporosis	0.000394	0.00158	CcSEcCtD
Methysergide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000391	0.00157	CcSEcCtD
Methysergide—Nausea—Calcitriol—osteoporosis	0.000389	0.00156	CcSEcCtD
Methysergide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000387	0.00155	CcSEcCtD
Methysergide—Arthralgia—Estradiol—osteoporosis	0.000385	0.00154	CcSEcCtD
Methysergide—Chest pain—Estradiol—osteoporosis	0.000385	0.00154	CcSEcCtD
Methysergide—Myalgia—Estradiol—osteoporosis	0.000385	0.00154	CcSEcCtD
Methysergide—Discomfort—Estradiol—osteoporosis	0.00038	0.00152	CcSEcCtD
Methysergide—Abdominal pain—Zoledronate—osteoporosis	0.000378	0.00152	CcSEcCtD
Methysergide—Body temperature increased—Zoledronate—osteoporosis	0.000378	0.00152	CcSEcCtD
Methysergide—Diarrhoea—Risedronate—osteoporosis	0.000377	0.00151	CcSEcCtD
Methysergide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000377	0.00151	CcSEcCtD
Methysergide—Asthenia—Pamidronate—osteoporosis	0.000376	0.00151	CcSEcCtD
Methysergide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000374	0.0015	CcSEcCtD
Methysergide—Oedema—Estradiol—osteoporosis	0.000369	0.00148	CcSEcCtD
Methysergide—Dizziness—Risedronate—osteoporosis	0.000364	0.00146	CcSEcCtD
Methysergide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000364	0.00146	CcSEcCtD
Methysergide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000364	0.00146	CcSEcCtD
Methysergide—Tachycardia—Estradiol—osteoporosis	0.00036	0.00144	CcSEcCtD
Methysergide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000359	0.00144	CcSEcCtD
Methysergide—Diarrhoea—Pamidronate—osteoporosis	0.000358	0.00144	CcSEcCtD
Methysergide—Rash—Ethinyl Estradiol—osteoporosis	0.000356	0.00143	CcSEcCtD
Methysergide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000356	0.00143	CcSEcCtD
Methysergide—Vomiting—Risedronate—osteoporosis	0.00035	0.00141	CcSEcCtD
Methysergide—Rash—Risedronate—osteoporosis	0.000347	0.00139	CcSEcCtD
Methysergide—Dermatitis—Risedronate—osteoporosis	0.000347	0.00139	CcSEcCtD
Methysergide—Dizziness—Pamidronate—osteoporosis	0.000346	0.00139	CcSEcCtD
Methysergide—Asthenia—Zoledronate—osteoporosis	0.000343	0.00138	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000336	0.00135	CcSEcCtD
Methysergide—Nausea—Ethinyl Estradiol—osteoporosis	0.000336	0.00135	CcSEcCtD
Methysergide—Insomnia—Estradiol—osteoporosis	0.000333	0.00134	CcSEcCtD
Methysergide—Vomiting—Pamidronate—osteoporosis	0.000333	0.00134	CcSEcCtD
Methysergide—Paraesthesia—Estradiol—osteoporosis	0.000331	0.00133	CcSEcCtD
Methysergide—Asthenia—Conjugated Estrogens—osteoporosis	0.000331	0.00133	CcSEcCtD
Methysergide—Rash—Pamidronate—osteoporosis	0.00033	0.00132	CcSEcCtD
Methysergide—Dermatitis—Pamidronate—osteoporosis	0.00033	0.00132	CcSEcCtD
Methysergide—Dyspnoea—Estradiol—osteoporosis	0.000329	0.00132	CcSEcCtD
Methysergide—Somnolence—Estradiol—osteoporosis	0.000328	0.00131	CcSEcCtD
Methysergide—Diarrhoea—Zoledronate—osteoporosis	0.000327	0.00131	CcSEcCtD
Methysergide—Nausea—Risedronate—osteoporosis	0.000327	0.00131	CcSEcCtD
Methysergide—Dyspepsia—Estradiol—osteoporosis	0.000325	0.0013	CcSEcCtD
Methysergide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000318	0.00128	CcSEcCtD
Methysergide—Fatigue—Estradiol—osteoporosis	0.000318	0.00128	CcSEcCtD
Methysergide—Dizziness—Zoledronate—osteoporosis	0.000316	0.00127	CcSEcCtD
Methysergide—Pain—Estradiol—osteoporosis	0.000315	0.00126	CcSEcCtD
Methysergide—Constipation—Estradiol—osteoporosis	0.000315	0.00126	CcSEcCtD
Methysergide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000315	0.00126	CcSEcCtD
Methysergide—Nausea—Pamidronate—osteoporosis	0.000311	0.00125	CcSEcCtD
Methysergide—Dizziness—Conjugated Estrogens—osteoporosis	0.000305	0.00122	CcSEcCtD
Methysergide—Vomiting—Zoledronate—osteoporosis	0.000304	0.00122	CcSEcCtD
Methysergide—Feeling abnormal—Estradiol—osteoporosis	0.000304	0.00122	CcSEcCtD
Methysergide—Rash—Zoledronate—osteoporosis	0.000302	0.00121	CcSEcCtD
Methysergide—Gastrointestinal pain—Estradiol—osteoporosis	0.000301	0.00121	CcSEcCtD
Methysergide—Dermatitis—Zoledronate—osteoporosis	0.000301	0.00121	CcSEcCtD
Methysergide—Vomiting—Conjugated Estrogens—osteoporosis	0.000293	0.00118	CcSEcCtD
Methysergide—Body temperature increased—Estradiol—osteoporosis	0.000291	0.00117	CcSEcCtD
Methysergide—Abdominal pain—Estradiol—osteoporosis	0.000291	0.00117	CcSEcCtD
Methysergide—Rash—Conjugated Estrogens—osteoporosis	0.00029	0.00117	CcSEcCtD
Methysergide—Dermatitis—Conjugated Estrogens—osteoporosis	0.00029	0.00116	CcSEcCtD
Methysergide—Nausea—Zoledronate—osteoporosis	0.000284	0.00114	CcSEcCtD
Methysergide—Nausea—Conjugated Estrogens—osteoporosis	0.000274	0.0011	CcSEcCtD
Methysergide—Asthenia—Estradiol—osteoporosis	0.000265	0.00106	CcSEcCtD
Methysergide—Diarrhoea—Estradiol—osteoporosis	0.000252	0.00101	CcSEcCtD
Methysergide—Dizziness—Estradiol—osteoporosis	0.000244	0.000978	CcSEcCtD
Methysergide—Vomiting—Estradiol—osteoporosis	0.000234	0.00094	CcSEcCtD
Methysergide—Rash—Estradiol—osteoporosis	0.000232	0.000933	CcSEcCtD
Methysergide—Dermatitis—Estradiol—osteoporosis	0.000232	0.000932	CcSEcCtD
Methysergide—Nausea—Estradiol—osteoporosis	0.000219	0.000879	CcSEcCtD
Methysergide—HTR1B—Signaling by GPCR—ADCY5—osteoporosis	3.47e-05	0.000597	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—WNT1—osteoporosis	3.4e-05	0.000585	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PTHLH—osteoporosis	3.36e-05	0.000579	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—BMP2—osteoporosis	3.36e-05	0.000579	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PTHLH—osteoporosis	3.36e-05	0.000579	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—BMP2—osteoporosis	3.36e-05	0.000579	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—BMP2—osteoporosis	3.34e-05	0.000575	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PTHLH—osteoporosis	3.34e-05	0.000575	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—FGA—osteoporosis	3.3e-05	0.000569	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—FGB—osteoporosis	3.29e-05	0.000567	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—FGB—osteoporosis	3.29e-05	0.000566	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—ADCY5—osteoporosis	3.27e-05	0.000563	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PTHLH—osteoporosis	3.27e-05	0.000563	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—BMP2—osteoporosis	3.27e-05	0.000563	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—POMC—osteoporosis	3.27e-05	0.000563	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—FGB—osteoporosis	3.27e-05	0.000563	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—IL6—osteoporosis	3.26e-05	0.000561	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—ADCY5—osteoporosis	3.26e-05	0.000561	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CALCA—osteoporosis	3.21e-05	0.000552	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—FGB—osteoporosis	3.2e-05	0.000551	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PSMA5—osteoporosis	3.18e-05	0.000547	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PSMA2—osteoporosis	3.18e-05	0.000547	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PSMA5—osteoporosis	3.17e-05	0.000547	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PSMA2—osteoporosis	3.17e-05	0.000547	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—SPP1—osteoporosis	3.16e-05	0.000545	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PSMA5—osteoporosis	3.15e-05	0.000543	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PSMA2—osteoporosis	3.15e-05	0.000543	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TLN1—osteoporosis	3.1e-05	0.000533	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—P4HB—osteoporosis	3.09e-05	0.000532	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PSMA2—osteoporosis	3.09e-05	0.000532	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PSMA5—osteoporosis	3.09e-05	0.000532	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—ADCY5—osteoporosis	3.08e-05	0.000531	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—P4HB—osteoporosis	3.07e-05	0.000529	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PTHLH—osteoporosis	3.07e-05	0.000529	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—BMP2—osteoporosis	3.07e-05	0.000529	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PTH—osteoporosis	3.01e-05	0.000517	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—FGB—osteoporosis	3.01e-05	0.000517	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PTH—osteoporosis	2.99e-05	0.000515	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—SPP1—osteoporosis	2.98e-05	0.000514	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CALCA—osteoporosis	2.96e-05	0.00051	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CALCA—osteoporosis	2.96e-05	0.000509	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—RAP1A—osteoporosis	2.95e-05	0.000509	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CALCA—osteoporosis	2.94e-05	0.000506	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—RAP1A—osteoporosis	2.94e-05	0.000506	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CNR2—osteoporosis	2.93e-05	0.000504	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CNR2—osteoporosis	2.91e-05	0.000502	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—ADCY5—osteoporosis	2.91e-05	0.000501	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PSMA2—osteoporosis	2.9e-05	0.0005	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PSMA5—osteoporosis	2.9e-05	0.0005	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.9e-05	0.000499	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—ADCY5—osteoporosis	2.89e-05	0.000498	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—POMC—osteoporosis	2.89e-05	0.000497	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—POMC—osteoporosis	2.89e-05	0.000497	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NFATC1—osteoporosis	2.88e-05	0.000496	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CALCA—osteoporosis	2.88e-05	0.000496	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—POMC—osteoporosis	2.87e-05	0.000494	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NFATC1—osteoporosis	2.87e-05	0.000494	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IRS2—osteoporosis	2.86e-05	0.000493	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DKK1—osteoporosis	2.86e-05	0.000492	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DKK1—osteoporosis	2.84e-05	0.00049	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—POMC—osteoporosis	2.81e-05	0.000483	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—LEP—osteoporosis	2.8e-05	0.000482	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—WNT1—osteoporosis	2.75e-05	0.000474	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—WNT1—osteoporosis	2.74e-05	0.000472	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CALCA—osteoporosis	2.7e-05	0.000466	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IRS2—osteoporosis	2.7e-05	0.000465	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—KL—osteoporosis	2.69e-05	0.000463	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—KL—osteoporosis	2.69e-05	0.000463	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FGA—osteoporosis	2.68e-05	0.000461	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—ESR1—osteoporosis	2.67e-05	0.00046	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—KL—osteoporosis	2.67e-05	0.00046	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—P4HB—osteoporosis	2.67e-05	0.00046	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FGA—osteoporosis	2.67e-05	0.000459	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—LEP—osteoporosis	2.64e-05	0.000455	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—ADCY5—osteoporosis	2.64e-05	0.000455	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—POMC—osteoporosis	2.64e-05	0.000454	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—ADCY5—osteoporosis	2.63e-05	0.000452	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—POMC—osteoporosis	2.62e-05	0.000452	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—POMC—osteoporosis	2.62e-05	0.000451	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—KL—osteoporosis	2.61e-05	0.00045	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—POMC—osteoporosis	2.6e-05	0.000448	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PTH—osteoporosis	2.6e-05	0.000447	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL6R—osteoporosis	2.56e-05	0.000441	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL6R—osteoporosis	2.56e-05	0.00044	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—RAP1A—osteoporosis	2.55e-05	0.000439	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—POMC—osteoporosis	2.55e-05	0.000439	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL6R—osteoporosis	2.54e-05	0.000437	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CNR2—osteoporosis	2.53e-05	0.000436	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—ESR1—osteoporosis	2.52e-05	0.000434	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.52e-05	0.000434	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—ADCY5—osteoporosis	2.51e-05	0.000432	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IRS1—osteoporosis	2.5e-05	0.00043	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PTHLH—osteoporosis	2.49e-05	0.000429	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—BMP2—osteoporosis	2.49e-05	0.000429	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NFATC1—osteoporosis	2.49e-05	0.000429	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL6R—osteoporosis	2.49e-05	0.000428	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PTHLH—osteoporosis	2.48e-05	0.000427	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—BMP2—osteoporosis	2.48e-05	0.000427	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DKK1—osteoporosis	2.47e-05	0.000425	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—KL—osteoporosis	2.46e-05	0.000423	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FGB—osteoporosis	2.44e-05	0.00042	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FGB—osteoporosis	2.42e-05	0.000417	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—POMC—osteoporosis	2.4e-05	0.000414	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—POMC—osteoporosis	2.39e-05	0.000412	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—WNT1—osteoporosis	2.38e-05	0.00041	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IRS1—osteoporosis	2.36e-05	0.000406	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PSMA2—osteoporosis	2.35e-05	0.000405	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PSMA5—osteoporosis	2.35e-05	0.000405	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL6R—osteoporosis	2.35e-05	0.000404	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PSMA2—osteoporosis	2.34e-05	0.000403	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PSMA5—osteoporosis	2.34e-05	0.000403	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL6R—osteoporosis	2.34e-05	0.000402	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FGA—osteoporosis	2.31e-05	0.000398	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IGF1—osteoporosis	2.31e-05	0.000398	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—ADCY5—osteoporosis	2.28e-05	0.000393	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—POMC—osteoporosis	2.27e-05	0.000391	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL6R—osteoporosis	2.21e-05	0.000381	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CALCA—osteoporosis	2.19e-05	0.000378	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IGF1—osteoporosis	2.18e-05	0.000376	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CALCA—osteoporosis	2.18e-05	0.000376	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—BMP2—osteoporosis	2.15e-05	0.00037	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PTHLH—osteoporosis	2.15e-05	0.00037	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—POMC—osteoporosis	2.14e-05	0.000368	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—POMC—osteoporosis	2.13e-05	0.000366	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ADCY5—osteoporosis	2.11e-05	0.000363	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FGB—osteoporosis	2.11e-05	0.000363	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ADCY5—osteoporosis	2.1e-05	0.000362	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ADCY5—osteoporosis	2.09e-05	0.00036	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ADCY5—osteoporosis	2.05e-05	0.000353	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SPP1—osteoporosis	2.04e-05	0.000351	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SPP1—osteoporosis	2.04e-05	0.000351	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PSMA5—osteoporosis	2.03e-05	0.00035	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PSMA2—osteoporosis	2.03e-05	0.00035	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SPP1—osteoporosis	2.02e-05	0.000348	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—KL—osteoporosis	1.99e-05	0.000343	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SPP1—osteoporosis	1.98e-05	0.000341	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—KL—osteoporosis	1.98e-05	0.000341	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—POMC—osteoporosis	1.94e-05	0.000334	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—POMC—osteoporosis	1.93e-05	0.000333	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ADCY5—osteoporosis	1.92e-05	0.000331	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL6R—osteoporosis	1.89e-05	0.000326	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CALCA—osteoporosis	1.89e-05	0.000326	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL6R—osteoporosis	1.88e-05	0.000324	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SPP1—osteoporosis	1.86e-05	0.00032	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—POMC—osteoporosis	1.85e-05	0.000318	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IRS2—osteoporosis	1.84e-05	0.000317	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IRS2—osteoporosis	1.84e-05	0.000317	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IRS2—osteoporosis	1.83e-05	0.000315	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—LEP—osteoporosis	1.8e-05	0.000311	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—LEP—osteoporosis	1.8e-05	0.00031	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.79e-05	0.000308	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—LEP—osteoporosis	1.79e-05	0.000308	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—IL6—osteoporosis	1.77e-05	0.000305	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—LEP—osteoporosis	1.75e-05	0.000302	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ESR1—osteoporosis	1.72e-05	0.000297	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ESR1—osteoporosis	1.72e-05	0.000296	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—KL—osteoporosis	1.72e-05	0.000296	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.71e-05	0.000294	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IRS2—osteoporosis	1.68e-05	0.00029	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.68e-05	0.000289	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.67e-05	0.000288	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—IL6—osteoporosis	1.67e-05	0.000287	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—LEP—osteoporosis	1.65e-05	0.000284	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.64e-05	0.000282	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IRS1—osteoporosis	1.61e-05	0.000277	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IRS1—osteoporosis	1.61e-05	0.000277	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.6e-05	0.000275	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.57e-05	0.000271	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.56e-05	0.000269	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.56e-05	0.000269	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.55e-05	0.000267	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—POMC—osteoporosis	1.55e-05	0.000267	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—POMC—osteoporosis	1.55e-05	0.000267	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—POMC—osteoporosis	1.54e-05	0.000265	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6R—osteoporosis	1.51e-05	0.00026	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6R—osteoporosis	1.51e-05	0.00026	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.51e-05	0.00026	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—POMC—osteoporosis	1.51e-05	0.000259	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.5e-05	0.000258	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.5e-05	0.000258	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IGF1—osteoporosis	1.49e-05	0.000257	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IGF1—osteoporosis	1.49e-05	0.000256	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.48e-05	0.000255	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.47e-05	0.000253	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.47e-05	0.000253	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.45e-05	0.000249	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—POMC—osteoporosis	1.41e-05	0.000244	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MYC—osteoporosis	1.39e-05	0.000239	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TGFB1—osteoporosis	1.39e-05	0.000239	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.38e-05	0.000238	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.36e-05	0.000235	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.36e-05	0.000234	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.36e-05	0.000234	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.35e-05	0.000232	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—LEP—osteoporosis	1.34e-05	0.00023	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—LEP—osteoporosis	1.33e-05	0.000229	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MYC—osteoporosis	1.31e-05	0.000226	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TGFB1—osteoporosis	1.31e-05	0.000225	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.3e-05	0.000224	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.27e-05	0.00022	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.27e-05	0.000218	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.19e-05	0.000205	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.19e-05	0.000204	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.18e-05	0.000203	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—LEP—osteoporosis	1.15e-05	0.000199	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—POMC—osteoporosis	1.15e-05	0.000198	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—POMC—osteoporosis	1.14e-05	0.000196	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL6—osteoporosis	1.14e-05	0.000196	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL6—osteoporosis	1.14e-05	0.000196	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.13e-05	0.000195	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.12e-05	0.000193	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.11e-05	0.000192	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.11e-05	0.000191	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.1e-05	0.00019	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.1e-05	0.00019	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.1e-05	0.000189	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL6—osteoporosis	1.05e-05	0.00018	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL6—osteoporosis	1.04e-05	0.000179	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.03e-05	0.000177	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—POMC—osteoporosis	9.91e-06	0.000171	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL6—osteoporosis	9.86e-06	0.00017	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6R—osteoporosis	9.67e-06	0.000166	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF1—osteoporosis	9.53e-06	0.000164	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MYC—osteoporosis	8.96e-06	0.000154	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MYC—osteoporosis	8.95e-06	0.000154	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TGFB1—osteoporosis	8.94e-06	0.000154	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TGFB1—osteoporosis	8.93e-06	0.000154	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MYC—osteoporosis	8.89e-06	0.000153	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TGFB1—osteoporosis	8.87e-06	0.000153	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MYC—osteoporosis	8.7e-06	0.00015	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TGFB1—osteoporosis	8.68e-06	0.00015	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL6—osteoporosis	8.44e-06	0.000145	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL6—osteoporosis	8.39e-06	0.000145	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MYC—osteoporosis	8.18e-06	0.000141	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TGFB1—osteoporosis	8.16e-06	0.00014	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6—osteoporosis	7.29e-06	0.000126	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6—osteoporosis	6.73e-06	0.000116	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6—osteoporosis	6.73e-06	0.000116	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6—osteoporosis	6.68e-06	0.000115	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MYC—osteoporosis	6.63e-06	0.000114	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TGFB1—osteoporosis	6.62e-06	0.000114	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MYC—osteoporosis	6.6e-06	0.000114	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TGFB1—osteoporosis	6.58e-06	0.000113	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6—osteoporosis	6.54e-06	0.000113	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6—osteoporosis	6.15e-06	0.000106	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MYC—osteoporosis	5.73e-06	9.86e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TGFB1—osteoporosis	5.71e-06	9.84e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6—osteoporosis	4.98e-06	8.58e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6—osteoporosis	4.96e-06	8.54e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6—osteoporosis	4.31e-06	7.41e-05	CbGpPWpGaD
